amino acid residue subjected to mutagenesis are marked by an asterisk. Alignments were assemled using "COBALT" (1) tool and visualised with "BioEdit 7.0.5" (2) . Homologous sequences with different similarity to Cas9 protein from Streptococcus thermophilus DGCC7710 CRISPR3 system were used for construction of alignment. GeneBank identification numbers of proteins are given in the left. Amino acid residues subjected to mutagenesis are marked by an asterisk. Alignments were assemled using "SMART 6" database (3). Homologous sequences with different similarity to Cas9 protein from Streptococcus thermophilus DGCC7710 CRISPR3 system were used for construction of alignment. UniProt accession numbers of proteins are given in the left.
Supplementary Figure 4.
Insertion of the anti-λ-spacer into the pCRISPR3 plasmid. Anti-λ-spacer was designed by selecting a sequence within the phage lambda o gene important for the phage genome replication. The protospacer sequence in the phage genome was adjacent to the PAM sequence (TGGTG) identical to that used in the plasmid transformation assay. Insertion of the anti-λ-spacer into the pCRISPR3 plasmid was performed in several steps. First, the unique SapI restriction endonuclease site was removed from pCRISPR3 plasmid by XbaI-SapI cleavage followed by re-ligation with T4 DNA ligase to generate pCRISPR3-ΔSapI plasmid. The anti-λ spacer insertion required two additional cloning steps (I and II). In the step I, PCR fragment amplified from pCRISPR3 plasmid with following primer pair: 5'-GACCACTTATTGAGGTAAATGAG-3'/5'-AACCAGGATCCAAGCTAATAGCTCTTCAGT TTTGGAACCATTC-3' (SapI (GCTCTTC) and BamHI (GGATCC) sites are underlined) was cloned into pCRISPR-ΔSapI plasmid pre-cleaved with Eco31I and BamHI to introduce the SapI site after the second repeat and remove remaining part of CRISPR region. In the second cloning step II, the synthetic oligoduplex containing spacer and repeat unit and sticky ends for the SapI and BamHI restriction endonucleases was assembled (5'-AACCCACCCAGCAAAATTCGGTTTTCTGGCTGAGTTTTAGAGCTGTGTTGTTTCGAA TGGTTCCAAAACG-3'/5'-GATCCGTTTTGGAACCATTCGAAACAACACAGCTCTAAAACT CAGCCAGAAAACCGAATTTTGCTGGGTGG -3', the anti-λ spacer sequence are underlined) and cloned into pCRISPR3-2R-SapI plasmid through SapI and BamHI sites to yield pCRISPR3-anti-λ-SP plasmid containing the anti-λ spacer in second position.
